Skip Navigation LinksHome > September 2005 - Volume 11 - Issue 9 > The Emerging Role of Adipocytokines as Inflammatory Mediator...
Inflammatory Bowel Diseases:
doi: 10.1097/01.mib.0000178915.54264.8f
Basic Science Review

The Emerging Role of Adipocytokines as Inflammatory Mediators in Inflammatory Bowel Disease

Karmiris, Konstantinos MD1; Koutroubakis, Ioannis E MD1,*; Kouroumalis, Elias A MD, PhD1

Collapse Box

Abstract

Anorexia, malnutrition, altered body composition and development of mesenteric obesity are well known features of inflammatory bowel disease (IBD). Recent data suggest that dysregulation of protein secretion by white adipose tissue is involved in these manifestations of patients with IBD. Adipocytes are recently recognized as endocrine cells that secrete a variety of bioactive substances known as adipocytokines. There is evidence that adipocytokines are involved in inflammatory and metabolic pathways in human beings. Overexpression of adipocytokines such as leptin, adiponectin and resistin in mesenteric adipose tissue of operated patients with Crohn's disease has recently been reported, suggesting that mesenteric adipocytes in IBD may act as immunoregulating cells. Therefore, it could be suggested that adipocytokines play an important role in the disease pathogenesis. Moreover, modulators of mesenteric adipose function have been suggested as potential therapeutic drugs in IBD. In this review, the importance of white adipose tissue function and adipocytokines, is discussed with respect to IBD.

© Crohn's & Colitis Foundation of America, Inc.

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.